155 related articles for article (PubMed ID: 29194195)
1. Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer.
Kang S; Thompson Z; McClung EC; Abdallah R; Lee JK; Gonzalez-Bosquet J; Wenham RM; Chon HS
Int J Gynecol Cancer; 2018 Feb; 28(2):260-266. PubMed ID: 29194195
[TBL] [Abstract][Full Text] [Related]
2. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
[TBL] [Abstract][Full Text] [Related]
3. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
[TBL] [Abstract][Full Text] [Related]
4. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
Pollom EL; Conklin CM; von Eyben R; Folkins AK; Kidd EA
Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977
[TBL] [Abstract][Full Text] [Related]
5. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-based risk model for preoperative prediction of lymph-node metastases in women with endometrial cancer: model-development study.
Eriksson LSE; Epstein E; Testa AC; Fischerova D; Valentin L; Sladkevicius P; Franchi D; Frühauf F; Fruscio R; Haak LA; Opolskiene G; Mascilini F; Alcazar JL; Van Holsbeke C; Chiappa V; Bourne T; Lindqvist PG; Van Calster B; Timmerman D; Verbakel JY; Van den Bosch T; Wynants L
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):443-452. PubMed ID: 31840873
[TBL] [Abstract][Full Text] [Related]
7. The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer.
Garg G; Gao F; Wright JD; Hagemann AR; Zighelboim I; Mutch DG; Powell MA
Int J Gynecol Cancer; 2013 Jan; 23(1):90-7. PubMed ID: 23196758
[TBL] [Abstract][Full Text] [Related]
8. Staging for endometrial cancer: The controversy around lymphadenectomy - Can this be resolved?
Koskas M; Rouzier R; Amant F
Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):845-57. PubMed ID: 25817745
[TBL] [Abstract][Full Text] [Related]
9. The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
Gynecol Oncol; 2018 Mar; 148(3):485-490. PubMed ID: 29290489
[TBL] [Abstract][Full Text] [Related]
10. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
12. Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray.
Bidus MA; Risinger JI; Chandramouli GV; Dainty LA; Litzi TJ; Berchuck A; Barrett JC; Maxwell GL
Clin Cancer Res; 2006 Jan; 12(1):83-8. PubMed ID: 16397028
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer.
Backes FJ; Walker CJ; Goodfellow PJ; Hade EM; Agarwal G; Mutch D; Cohn DE; Suarez AA
Gynecol Oncol; 2016 May; 141(2):312-317. PubMed ID: 26957478
[TBL] [Abstract][Full Text] [Related]
14. Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer.
Lee J; Kong TW; Paek J; Chang SJ; Ryu HS
Int J Gynecol Cancer; 2016 Nov; 26(9):1630-1635. PubMed ID: 27654258
[TBL] [Abstract][Full Text] [Related]
15. Lymph node status did not significantly improve the predictability of survival in patients with clinically early-stage endometrial cancer.
Bae HS; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT; Kang S
Int J Gynecol Cancer; 2014 Oct; 24(8):1449-54. PubMed ID: 25180462
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group.
Stålberg K; Kjølhede P; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Falconer H; Holmberg E; Staf C; Tholander B; Åvall-Lundqvist E; Rosenberg P; Högberg T
Int J Cancer; 2017 Jun; 140(12):2693-2700. PubMed ID: 28340503
[TBL] [Abstract][Full Text] [Related]
17. Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification.
Zuo J; Wu LY; Cheng M; Bai P; Lei CZ; Li N; Zhang GY; Zhao D; Li B
J Minim Invasive Gynecol; 2019; 26(6):1125-1132. PubMed ID: 30445188
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
[No Abstract] [Full Text] [Related]
19. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
[TBL] [Abstract][Full Text] [Related]
20. MiRNAs in endometrioid endometrial cancer metastatic loci derived from positive lymph nodes.
Wilczynski M; Senderowska D; Krawczyk T; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1085-1091. PubMed ID: 32100871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
